How to buy Ekso Bionics stock

Ekso Bionics Holdings, Inc is a medical instruments & supplies business based in the US. Ekso Bionics shares (EKSO) are listed on the NASDAQ and all prices are listed in US Dollars. Ekso Bionics employs 39 staff and has a trailing 12-month revenue of around 0.00.

Ekso Bionics share price

Use our graph to track the performance of EKSO stocks over time.

Ekso Bionics shares at a glance

• Key figures

Information last updated 2021-04-30.

52-week range	$2.80 - $11.10
50-day moving average	$6.26
200-day moving average	$6.51
Wall St. target price	$10.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.32

Buy Ekso Bionics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Ekso Bionics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Ekso Bionics Holdings, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Ekso Bionics financials

Revenue TTM	$8.9 million
Gross profit TTM	$5.1 million
Return on assets TTM	-37.81%
Return on equity TTM	-281.81%
Profit margin	-178.17%
Book value	$0.53
Market capitalisation	$64.5 million

TTM: trailing 12 months

Shorting Ekso Bionics shares

There are currently 286,226 Ekso Bionics shares held short by investors – that's known as Ekso Bionics's "short interest". This figure is 67.4% up from 170,997 last month.

There are a few different ways that this level of interest in shorting Ekso Bionics shares can be evaluated.

Ekso Bionics's "short interest ratio" (SIR)

Ekso Bionics's "short interest ratio" (SIR) is the quantity of Ekso Bionics shares currently shorted divided by the average quantity of Ekso Bionics shares traded daily (recently around 461654.83870968). Ekso Bionics's SIR currently stands at 0.62. In other words for every 100,000 Ekso Bionics shares traded daily on the market, roughly 620 shares are currently held short.

However Ekso Bionics's short interest can also be evaluated against the total number of Ekso Bionics shares, or, against the total number of tradable Ekso Bionics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ekso Bionics's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Ekso Bionics shares in existence, roughly 20 shares are currently held short) or 0.0243% of the tradable shares (for every 100,000 tradable Ekso Bionics shares, roughly 24 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ekso Bionics.

Find out more about how you can short Ekso Bionics stock.

Ekso Bionics share dividends

We're not expecting Ekso Bionics to pay a dividend over the next 12 months.

Have Ekso Bionics's shares ever split?

Ekso Bionics's shares were split on a 1:15 basis on 24 March 2020. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ekso Bionics shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Ekso Bionics shares which in turn could have impacted Ekso Bionics's share price.

Ekso Bionics share price volatility

Over the last 12 months, Ekso Bionics's shares have ranged in value from as little as $2.8 up to $11.1. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ekso Bionics's is 2.278. This would suggest that Ekso Bionics's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Ekso Bionics overview

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells, and rents exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation and OttoBock Healthcare Product GmbH.

Frequently asked questions

• What percentage of Ekso Bionics is owned by insiders or institutions?

  Currently 7.726% of Ekso Bionics shares are held by insiders and 9.796% by institutions.

• How many people work for Ekso Bionics?

  Latest data suggests 39 work at Ekso Bionics.

• When does the fiscal year end for Ekso Bionics?

  Ekso Bionics's fiscal year ends in December.

• Where is Ekso Bionics based?

  Ekso Bionics's address is: 1414 Harbour Way South, Richmond, CA, United States, 94804

• What is Ekso Bionics's ISIN number?

  Ekso Bionics's international securities identification number is: US2826443010

• What is Ekso Bionics's CUSIP number?

  Ekso Bionics's Committee on Uniform Securities Identification Procedures number is: 282644103